As of Sep 22
| +0.30 / +5.10%|
The 1 analysts offering 12-month price forecasts for MediciNova Inc have a median target of 6.72, with a high estimate of 6.72 and a low estimate of 6.72. The median estimate represents a +8.73% increase from the last price of 6.18.
The current consensus among 1 polled investment analysts is to Buy stock in MediciNova Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.